STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Becton Dickinson insider files Form 144 to sell 58 RSU shares on NYSE

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Becton Dickinson & Co. (BDX) Form 144 shows a proposed sale of 58 shares of common stock through Morgan Stanley Smith Barney with an aggregate market value of $10,474.22 and an approximate sale date of 09/26/2025 on the NYSE. The shares were acquired as Restricted Stock Units on 08/20/2025. The filing also discloses a prior 10b5-1 sale of 57 shares on 08/22/2025 with gross proceeds of $11,285.43. The form lists total shares outstanding as 286,627,469. Several filer contact fields and issuer identification fields are blank in the provided content.

Positive

  • Securities were acquired as Restricted Stock Units, clearly dated 08/20/2025 providing a clear acquisition record
  • Broker and marketplace disclosed: Morgan Stanley Smith Barney and NYSE are named for the proposed sale
  • Prior 10b5-1 sale disclosed (57 shares on 08/22/2025), which can indicate pre-planned trading activity

Negative

  • Key filer and issuer identification fields are blank in the provided extract (CIK/CCC, issuer SEC file number, issuer address), reducing traceability
  • No plan adoption or signature details shown in the extract if relying on a Rule 10b5-1 plan, which limits compliance verification
  • Very small transaction size may be immaterial to investors, offering limited information value

Insights

TL;DR: Routine insider disposition; very small position size relative to company float, likely non-material to shareholders.

The filing documents a proposed sale of 58 shares acquired as RSUs two weeks earlier. The transaction size and stated aggregate value are minor relative to the reported 286,627,469 shares outstanding, indicating limited market impact. The presence of a near-term prior 10b5-1 sale (57 shares on 08/22/2025) suggests the insider has been executing small dispositions. No earnings or operational data are disclosed here to alter the investment thesis.

TL;DR: Filing appears routine but lacks some identifying contact and issuer detail in the provided extract.

The form identifies the broker and transaction details but the provided tables omit filer CIK/CCC and issuer address/SEC file number fields, which are typically required for full provenance and regulatory tracking. The remarks section includes the standard Rule 144 and 10b5-1 attestations, but no plan adoption date or signature details are present in the extract; if relying on a trading plan, that date should be disclosed. Missing fields limit completeness for compliance review.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the BDX Form 144 report?

The filing reports a proposed sale of 58 shares of Becton Dickinson common stock with an aggregate market value of $10,474.22, to occur on 09/26/2025 on the NYSE.

How were the 58 BDX shares acquired?

The shares were acquired as Restricted Stock Units on 08/20/2025 according to the filing.

Was there any recent insider selling before this filing?

Yes. The document shows a prior 10b5-1 sale of 57 shares on 08/22/2025 with gross proceeds of $11,285.43.

Who is the broker handling the proposed sale?

The broker listed is Morgan Stanley Smith Barney LLC Executive Financial Services located at 1 New York Plaza, New York, NY.

How many BDX shares are outstanding according to the filing?

The filing lists 286,627,469 shares outstanding.
Becton Dickinson & Co

NYSE:BDX

BDX Rankings

BDX Latest News

BDX Latest SEC Filings

BDX Stock Data

57.21B
283.68M
0.57%
92.26%
1.59%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
FRANKLIN LAKES